Selenium treatment in rheumatoid arthritis.
A low selenium level has been reported in rheumatoid arthritis and juvenile chronic arthritis. Selenium is an essential part of the enzyme glutathione peroxidase, which catabolizes peroxides, compounds which are suggested to be of pathogenetic importance in rheumatic diseases. To assess a possible antirheumatic effect of selenium, 40 patients with active RA were included in a 6-month double-blind clinical study of selenium versus placebo. The patients in the selenium group were given daily supplements of 256 micrograms selenium in selenium-enriched yeast. Although concentrations of selenium in serum and erythrocytes increased considerably, no significant antirheumatic effect of selenium could be demonstrated.
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007700:Kinetics; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D012643:Selenium / Q000097:blood / Q000627:therapeutic use*; D012709:Serum Albumin / Q000032:analysis
D006454:Hemoglobins; D007136:Immunoglobulins; D012709:Serum Albumin; D012643:Selenium